A narrative review evaluates preclinical evidence for pairing the anesthetic dexmedetomidine with biomaterial scaffolds to ...
A retrospective single-center study found that adding low-dose dexmedetomidine to ciprofol was associated with fewer ...
Teva's celiac disease drug TEV-408 became the first treatment to protect celiac patients' intestines from gluten damage in a ...
Tech Times on MSN
Teva Pharmaceutical R&D Day 2026: First-in-class drugs for Tourette syndrome, celiac disease, and IBD scarring
Teva Pharmaceutical's inaugural R&D Day unveiled three first-in-class drugs targeting Tourette syndrome in children, celiac disease, and IBD -- conditions no approved therapy fully addresses -- ...
Series: "Delirium and Sleep Rhythms" #12Key Points of This IssueIn the previous meta-analysis, it was dexmedetomidine that ...
ASAM has issued its first national clinical considerations on recognizing and treating medetomidine use and withdrawal in the ...
BXCL501, a dexmedetomidine sublingual film, is under FDA review for first-ever at-home use for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults ...
Series: "Delirium and Sleep Rhythms" #11Key Points of This IssueChapter 3 discusses preventive interventions. Does regulating ...
Medetomidine is complicating withdrawal from illicit drugs, leaving people struggling to find treatment that can help them ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results